Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
crtx.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$56.15M

About Cornerstone Therapeutics

Cornerstone Therapeutics (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of Cornerstone's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within Cornerstone's focus areas; and generate revenues by marketing approved generic products through Cornerstone's wholly-owned subsidiary, Aristos Pharmaceuticals.

Cornerstone Therapeutics Headquarter Location

1255 Crescent Green Drive Suite 250

Cary, North Carolina, 27518,

United States

919-678-6611

Latest Cornerstone Therapeutics News

Cornerstone Therapeutics Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 3, 2016

Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 16:26 EST 3 Dec 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cornerstone Therapeutics, Inc. since January 2007. Key Findings Provides intelligence on Cornerstone Therapeutics, Inc.'s MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Cornerstone Therapeutics, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Cornerstone Therapeutics, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Cornerstone Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cornerstone Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cornerstone Therapeutics is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

11,639 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Cornerstone Therapeutics Patents

Cornerstone Therapeutics has filed 8 patents.

The 3 most popular patent topics include:

  • Inflammations
  • Lung disorders
  • Pneumonia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/29/2014

8/30/2016

Ion channels, Cannabinoids, Nicotinic acetylcholine receptors, Designer drugs, Nicotinic antagonists

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/29/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/30/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Ion channels, Cannabinoids, Nicotinic acetylcholine receptors, Designer drugs, Nicotinic antagonists

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.